Evidence for systems that carry regulated work.
The domain library organizes consequences that can share a system but require different evidence, expertise, owners, and decision criteria. It prevents one synthetic score from concealing materially different questions.
Risk that policies, procedures, specifications, instructions, forms, records, roles, and management oversight do not remain approved, current, available, attributable, and connected to the regulated work they govern.
Open the domain record →Risk that deviations, nonconformances, investigations, corrective and preventive actions, and changes are handled as isolated tickets rather than a controlled chain from detection through root cause, risk, implementation, and effectiveness review.
Open the domain record →Risk that the organization cannot retrieve a coherent, accurate, and reviewable evidence chain for an auditor, inspector, certification body, notified body, or internal governance review without manual reconstruction.
Open the domain record →Risk that a quality or regulatory system is not fit for intended use, remains insufficiently controlled through change, or cannot preserve complete, consistent, accurate, attributable, legible, contemporaneous, original, and available records across its lifecycle.
Open the domain record →Risk that suppliers, laboratories, contract manufacturers, service providers, and other external parties are selected, qualified, monitored, changed, and governed without sufficient evidence or connection to product and process risk.
Open the domain record →Risk that product, substance, device, market, registration, license, activity, authority, commitment, correspondence, and approval information is fragmented or too unreliable to support global regulatory decisions and market continuity.
Open the domain record →Risk that regulated content cannot be planned, authored, approved, assembled, validated, transmitted, received, and maintained in the correct format and lifecycle for the relevant authority and procedure.
Open the domain record →Risk that medicinal-product, device, substance, pack, presentation, identifier, label, and artwork data is inconsistent across source systems, submissions, authority databases, markets, safety processes, and supply operations.
Open the domain record →Risk that complaints, adverse-event indicators, product-quality complaints, vigilance, field actions, recalls, post-market surveillance, and regulatory reporting are delayed or fragmented across quality, safety, medical, regulatory, and commercial systems.
Open the domain record →